Macrophage migration inhibitory factor for earliest stage ST-segment elevation myocardial infarction
Background Macrophage migration inhibitory factor (MIF) is involved in the progress of atherosclerosis and plaque destabilization and plays a pivotal role in the development of ST-segment elevation myocardial infarction (STEMI).The aim of the present study was to study on the characteristics of MIF in time-dependent changes, to evaluate the diagnostic value of MIF for early STEMI (≤4 hours of onset) and late STEMI (＞4 hours after onset), and determine whether MIF can predict major adverse cardiovascular events (MACE) in the patients with STEMI while in the hospital, compared with admission global registry of acute coronary events (GRACE) risk score.
YANG Yi-ning GUO Jun-lin MA Yi-tong LI Xiao-mei SUN Hui-ping XIE Xiang LIU Fen Li Men
Department of Coronary Heart Disease,Cardiac Center,the First Affiliated Hospital to Xinjiang Medical University
国内会议
北京
英文
179-180
2013-03-20（万方平台首次上网日期，不代表论文的发表时间）